Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 626 - 650 of 774 in total
Silibinin is the major active constituent of silymarin, a standardized extract of the milk thistle seeds, containing a mixture of flavonolignans consisting of silibinin, isosilibinin, silicristin, silidianin and others. Silibinin is presented as a mixture of two diastereomers, silybin A and silybin B, which are found in an approximately equimolar...
Experimental
Investigational
Matched Products: … BILSYL CAPSULAS X 150 MG. …
Experimental
Matched Categories: … X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
XL888 has been used in trials studying the treatment of Cancer and Melanoma.
Investigational
Investigational
Acetrizoic acid presents the molecular formula of 3-acetamidol-2,4,6-triiodobenzoic acid and it is the first monomeric ionic compound used as an X-ray contrast agent. It was first synthesized by Wallingford in 1953 and it was filled in the FDA by the Johnson & Johnson subsidiary, Cilag Chemie AG, on February 8th,...
Withdrawn
Matched Description: … acetamidol-2,4,6-triiodobenzoic acid[L1702] and it is the first monomeric ionic compound used as an X-ray …
Matched Categories: … X-Ray Contrast Media, Iodinated ... Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media …
The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans.
Experimental
Investigational
LG-100268 is a retinoid X receptor (RXR) selective compound.
Experimental
Matched Description: … LG-100268 is a retinoid X receptor (RXR) selective compound. …
XAV-19 is an intravenous antibody-based treatment targeted towards SARS-CoV-2 and other coronaviruses[L16553,L16558]. The therapy concept is based on COVID-19 convalescent plasma. However, rather than using human plasma, XAV-19 is a heterologous swine glyco-humanized polyclonal antibody that targets the spike protein of SARS-CoV-2[L16553,L16558]. The therapy offers three beneficial effects: the ability...
Investigational
Investigational
XTL001 is an investigational monoclonal antibody (MAb) product developed by XTL Biopharmaceuticals to evaluate the safety profile and antiviral activity of the compound in patients chronically infected with hepatitis B virus (HBV).
Investigational
SPG601 is being investigated for the treatment of fragile X syndrome.
Investigational
Matched Description: … SPG601 is being investigated for the treatment of fragile X syndrome. …
XMT-2056 is a HER2-targeted antibody-drug conjugate (ADC) consisting of a HER2-targeted antibody conjugated with a stimulator of interferon genes (STING) agonist payload.
Investigational
Experimental
Matched Products: … THILO-TEARS SE GÖZ DAMLASI 0,5 GR X 20 TEK DOZ …
Experimental
Radiopaque medium used in the diagnosis of gall bladder & bile duct diseases, usually as meglumine salt.
Experimental
Matched Categories: … X-Ray Contrast Media, Iodinated ... Watersoluble, Hepatotropic X-Ray Contrast Media …
Xanomeline is under investigation in clinical trial NCT02831231 (Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium).
Investigational
Experimental
Eltanolone is under investigation in clinical trial NCT02603926 (Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone).
Investigational
Matched Description: … Eltanolone is under investigation in clinical trial NCT02603926 (Treatment of Fragile-X Associated Tremor …
Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the...
Nutraceutical
Matched Mixtures name: … Nutrilite Double X ... Nutrilite Double X ... Nutrilite Double X
Matched Products: … Ag-X
Investigational
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Matched Description: … LY518674 has been used in trials studying the treatment of Metabolic Syndrome X. …
Experimental
Matched Categories: … X-Ray Contrast Media, Iodinated ... Watersoluble, Hepatotropic X-Ray Contrast Media …
Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
Investigational
Matched Description: … Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food …
2X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP).
Investigational
Displaying drugs 626 - 650 of 774 in total